Coagulazione, infiammazione e CVD

Titolo	Data creazione	Visite
Empagliflozin enhances human and murine cardiomyocyte glucose uptake by increased expression of GLUT1	26 Marzo 2019	Visite: 88
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study	18 Febbraio 2019	Visite: 74
Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure. Benefits of SGLT2 Inhibitors	25 Gennaio 2019	Visite: 109
One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus	28 Dicembre 2018	Visite: 110
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction. The TOPCAT Trial	30 Novembre 2018	Visite: 75
Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes	02 Novembre 2018	Visite: 133
Mitochondrial oxidative stress, endothelial function and metabolic control in patients with type II diabetes and periodontitis: A randomised controlled clinical trial	09 Ottobre 2018	Visite: 91
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiotamediated metabolic health	11 Settembre 2018	Visite: 116
Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women	30 Luglio 2018	Visite: 112
The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes	17 Luglio 2018	Visite: 188

Pagina 1 di 6

Ricerca

Cookie